Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Sales | 41 | 5 | 0 | 54 | 53 |
| Gross Profit | 41 | 5 | N/A | 54 | 53 |
| Operating Expenses | 1,564 | 1,502 | 0 | 1,850 | 2,300 |
| Operating Income | -1,523 | -1,497 | N/A | -1,797 | -2,247 |
| Interest Expense | 0 | 2 | 0 | 4 | 5 |
| Other Income | 10 | 6 | 0 | 27 | 61 |
| Pre-tax Income | -1,514 | -1,493 | 0 | -1,773 | -2,191 |
| Net Income Continuous | -1,514 | -1,493 | N/A | -1,773 | -2,191 |
| Net Income Discontinuous | -24 | 32 | N/A | 61 | -492 |
| Net Income | $-1,537 | $-1,462 | $N/A | $-1,712 | $-2,682 |
| EPS Basic Total Ops | -7.68 | -7.68 | N/A | -9.60 | -15.37 |
| EPS Basic Continuous Ops | -7.68 | -7.68 | N/A | -9.60 | -13.45 |
| EPS Basic Discontinuous Ops | -0.11 | 0.18 | N/A | 0.35 | -1.92 |
| EPS Diluted Total Ops | -7.68 | -7.68 | N/A | -9.60 | -15.37 |
| EPS Diluted Continuous Ops | -7.68 | -7.68 | N/A | -9.60 | -13.45 |
| EPS Diluted Discontinuous Ops | -0.11 | 0.18 | N/A | 0.35 | -1.92 |
| EBITDA(a) | $-1,368 | $-1,343 | $N/A | $-1,631 | $-2,237 |